Sunday, June 26, 2022

A company insider recently bought 15,970 shares of GBS Inc. [GBS]. Should You buy?

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. GBS Inc. shares valued at $9,766 were purchased by Sakiris Spiro Kevin on Jun 17. At $0.61 per share, Sakiris Spiro Kevin acquired 15,970 shares. The insider’s holdings grew to 45,228 shares worth approximately $33921.0 following the completion of this transaction.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Also, Life Science Biosensor Diagnos sold 576,028 shares, netting a total of over 293,774 in proceeds. Following the sale of shares at $0.51 each, the insider now holds 1,081,804 shares.

Before that, Life Science Biosensor Diagnos had sold 100,000 shares from its account. In a trade valued at $63,000, the 10% Owner traded GBS Inc. shares for $0.63 each. Upon closing the transaction, the insider’s holdings decreased to 100,000 shares, worth approximately $1.24 million.

As published in a research note from JP Morgan on October 07, 2016, Merrimack Pharmaceuticals Inc. [MACK] has been rated down from an Overweight to a Neutral. Analysts at Robert W. Baird started covering the stock with ‘”a Neutral”‘ outlook in a report released in late May. As of December 23, 2015, Mizuho has reiterated its “Buy” rating for MACK. Earlier on October 27, 2015, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for MACK stock.

Analyzing GBS’s Price Performance

On Wednesday, GBS Inc. [NASDAQ: GBS] rose 13.10% to $0.75. The stock’s lowest price that day was $0.6614, but it reached a high of $0.7536 in the same session. During the last five days, there has been a surge of approximately 29.09%. Over the course of the year, GBS Inc. shares have dropped approximately -47.48%. Shares of the company reached a 52-week high of $1.9800 on 01/03/22 and a 52-week low of $0.3805 on 02/23/22. A 50-day SMA is recorded $0.6564, while a 200-day SMA reached $1.3725. Nevertheless, trading volume fell to 0.25 million shares from 94100.0 shares the previous day.

Support And Resistance Levels for GBS Inc. (GBS)

According to the 24-hour chart, there is a support level at 0.6921, which, if violated, would cause prices to drop to 0.6307. In the upper region, resistance lies at 0.7843. The next price resistance is at 0.8151. RSI (Relative Strength Index) is 69.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0853, which suggests the price will decrease in the coming days. Percent R is at 0.00%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Which companies own the most shares of GBS Inc. (GBS)?

According to Geode Capital Management LLC filings, the company currently owns 113,118 shares, which is about 0.76% of the total GBS shares outstanding. The investor’s shares have remained unchanged by 113,118 from its previous 13-F filing of 0.0 shares. With the completion of the transaction, Virtu Financial BD LLC’s stake is now worth $51,849. A total of 42,800 shares of GBS Inc. were sold by Goldman Sachs & Co. LLC during the quarter, and 19,395 were bought by Two Sigma Securities LLC. In its current portfolio, BlackRock Fund Advisors holds 29,549 shares valued at $17138.0.

In terms of GBS Inc. share price expectations, FactSet research, analysts set an average price target of $4.50 in the next 12 months, up nearly 571.64% from the previous closing price of $0.67. Analysts anticipate GBS Inc. stock to reach $4.50 by 2022, with the lowest price target being $4.50. In spite of this, 0 analysts ranked GBS Inc. stock as a – at the end of 2022.

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here

2618

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam